Michael Andriole is the founder of Chimerix. Chimerix has raised $268M in total funding. Based in Durham, North Carolina, USA.
Michael Andriole, former President and CEO of Chimerix Inc., has been appointed CEO of Artios Pharma Ltd., a DNA damage response company. Chimerix Inc. was acquired by Jazz Pharmaceuticals plc for $935 million. Artios Pharma Ltd. has raised at least $268 million since its founding in 2016.
Full founder directory · Investor directory · Company funding database · Fundraising library